PET studies of potential chemotherapeutic agents—X. Synthesis of “no-carrier-added” (11C)-HECNU: The hydroxyethyl analog of the chemotherapeutic agent BCNU
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes
- Vol. 42 (5) , 441-446
- https://doi.org/10.1016/0883-2889(91)90103-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PETJournal of Neuro-Oncology, 1991
- Influence of glutathione on the mutagenicity of 2-chloroethylnitrosoureasMutation Research/Genetic Toxicology, 1988
- Effect of HECNU in malignant supratentorial gliomas ? a phase II studyJournal of Neuro-Oncology, 1988
- Chemotherapy for malignant gliomasJournal of Neurosurgery, 1988
- Brain uptake and CNS levels of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea (HECNU)Investigational New Drugs, 1987
- Relative mutagenic and prophage-inducing effects of mono- and di-alkyl nitrosourcesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1987
- Synthesis of “no-carrier-added”11C-labelled nitrosoureasJournal of Radioanalytical and Nuclear Chemistry, 1985
- Synthesis of 18F-labelled 2-fluoroethyl-nitrosoureasCanadian Journal of Chemistry, 1984
- An on-line synthesis of “no-carrier-added” [11C]phosgeneInternational Journal of Nuclear Medicine and Biology, 1982
- Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potentialZeitschrift für Krebsforschung und Klinische Onkologie, 1976